This collaboration will mark a significant milestone in advancing LynxCare European expansion strategy, empower the clinical development platform of Keyrus Life Science, and support our shared commitment to harness the power of big data in healthcare to the benefit of patients, clinicians, hospitals, and research.

Keyrus Life Science is an advanced Contract Research Organization, established in Europe and in North America since more than 20 years. It is part of the Keyrus Group, an international actor in the technological transformation of organizations, through established data, digital and management capabilities.

LynxCare is a healthcare big data company helping hospitals unlock previously unavailable clinical insights through the use of NLP and AI, building OMOP-CDM health databases, for better patient care and scientific research, particularly in oncology and cardiology.

Keyrus Life Science’s expertise in clinical development for the #pharma and biotech/medtech industry, combined with Keyrus Group’s mastering of data and digital technologies perfectly complements LynxCare's pioneering work in unlocking the full potential of hospital data through NLP technology. We are convinced this synergy will further boost innovation in healthcare.

“We are thrilled to embark on this partnership journey with Keyrus Life Science and are proud to have already set the first successful steps in France, with new geographies on our horizon,” says Georges De Feu, CEO LynxCare. Michael Attlan, VP Life Science Keyrus group, adds “LynxCare will be a highly valuable partner to deliver innovative real-world data solutions to the life science sector. In addition, we share a common vision: making better and more efficient use of healthcare data to drive better health outcomes for all.”

Stay tuned for further updates on exciting joint projects!